Risk of hepatocellular carcinoma (HCC) recurrence in HCV cirrhotic patients treated with Direct Acting Antivirals (DAAs)
Cabibbo, G., Cacciola, I., Cannavò, M.R., Madonia, S., Calvaruso, V., Petta, S., Distefano, M., Larocca, L., Prestileo, T., Tinè, F., Digiacomo, A., Bertino, G., Giannitrapani, L., Benanti, F., Davì,Volume:
49
Language:
english
Journal:
Digestive and Liver Disease
DOI:
10.1016/j.dld.2017.01.119
Date:
February, 2017
File:
PDF, 46 KB
english, 2017